Disease map-based biomarker selection and pre-validation for bladder cancer diagnostic

Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
Marine De PaoliChristophe Marquette

Abstract

Urinary biomarkers are promising as simple alternatives to cystoscopy for the diagnosis of de novo and recurrent bladder cancer. To identify a highly sensitive and specific biomarker candidate set with potential clinical utility in bladder cancer. Urinary biomarker concentrations were determined by ELISA. The performance of individual markers and marker combinations was assessed using ROC analysis. A five-biomarker panel (IL8, MMP9, VEGFA, PTGS2 and EN2) was defined from the candidate set. This panel showed a better overall performance than the best individual marker. Further validation studies are needed to evaluate its clinical utility in bladder cancer.

References

Jun 1, 2005·European Urology·Bas W G van RhijnTheo H van der Kwast
Jan 25, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marta Sanchez-CarbayoCarlos Cordon-Cardo
May 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·A Karim KaderXifeng Wu
Nov 13, 2007·The Journal of Urology·M Craig HallPaul F Schellhammer
Dec 29, 2007·European Urology·Olaf P J Vrooman, J Alfred Witjes
Mar 28, 2008·Urologic Oncology·Jason GeeAnita L Sabichi
Aug 7, 2008·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·Lorne I BudmanJordan R Steinberg
Jan 6, 2009·International Journal of Urology : Official Journal of the Japanese Urological Association·Angela A G Van TilborgEllen C Zwarthoff
Nov 12, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shahrokh F ShariatYair Lotan
Mar 25, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·C Eric ThomasJohn Koomen
Oct 1, 2008·Proteomics. Clinical Applications·Niroshan RamachandranJoshua Labaer
Apr 5, 2011·European Urology·Marko BabjukUNKNOWN European Association of Urology (EAU)
May 26, 2012·PloS One·Virginia UrquidiSteve Goodison
Feb 26, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Richard MorganHardev Pandha
Apr 16, 2013·Journal of the National Comprehensive Cancer Network : JNCCN·Peter E ClarkUNKNOWN National Comprehensive Cancer Network (NCCN)
Apr 8, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jun PeiBaohui Han
May 3, 2014·Methods in Molecular Biology·Andreas HeinzelPaul Perco

❮ Previous
Next ❯

Citations

Sep 24, 2016·Disease Markers·Marine De PaoliChristophe Marquette
Dec 25, 2016·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Selma GogalicClaudia Preininger
May 10, 2019·Metabolites·Elizabeth C ConsidineLouise C Kenny
Mar 15, 2020·Scientific Reports·Priyanka BhadwalNavneet Agnihotri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Related Papers

Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
Marine De PaoliChristophe Marquette
BMJ : British Medical Journal
S Prescott, D A Tolley
© 2021 Meta ULC. All rights reserved